ImmunityBio recently reported that Macau’s Pharmaceutical Administration Bureau approved ANKTIVA (nogapendekin alfa inbakicept-pmln) plus BCG for adults with BCG-unresponsive non-muscle invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results